HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyroid exposure to scattered radiation and associated second cancer risk from paediatric radiotherapy for extracranial tumours.

Abstract
This study was conducted to estimate the scattered thyroid dose and relevant second cancer risk from radiotherapy for extracranial tumours during childhood.  Anteroposeterior and posteronaterior field irradiations employed during the treatment of Hodgkin's disease, neuroblastoma and Wilms' tumour were simulated on two humanoid phantoms representing 5- and 10-y-old patients. Measurements were performed using thermoluminescent dosemeters. Practical thyroid lead shields with thicknesses of 2-10 mm were placed in the phantoms' neck region. The lifetime risk for cancer induction was assessed using sex- and age-specific risk factors. Thyroid dose per monitor unit varied from 28.1 to 492.4 μGy by the primary irradiation site and patient's age. The 10-mm-thick lead shield led to a dose reduction up to 28.9 %. For typical prescribed tumour doses, the total risks for thyroid cancer development after radiotherapy of 5- and 10-y-old male patients were 0.05-0.99  and 0.03-0.48 %, respectively. The corresponding risks for females increased to 0.29-5.51 and 0.17-2.94 %.
AuthorsMichalis Mazonakis, Kalliopi Kourinou, Efrossini Lyraraki, Haralambos Varveris, John Damilakis
JournalRadiation protection dosimetry (Radiat Prot Dosimetry) Vol. 152 Issue 4 Pg. 317-22 (Dec 2012) ISSN: 1742-3406 [Electronic] England
PMID22504308 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Brain Neoplasms (epidemiology, radiotherapy)
  • Child
  • Comorbidity
  • Female
  • Humans
  • Incidence
  • Male
  • Neoplasms, Radiation-Induced (epidemiology)
  • Organs at Risk (radiation effects)
  • Radiation Dosage
  • Radiometry (statistics & numerical data)
  • Radiotherapy, Conformal (statistics & numerical data)
  • Risk Assessment (methods)
  • Scattering, Radiation
  • Thyroid Gland (radiation effects)
  • Thyroid Neoplasms (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: